Skip to content

Improving Psychosocial Quality of Life in Women With Advanced Breast Cancer

Improving Psychosocial Quality of Life in Women With Advanced Breast Cancer

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01811264
Enrollment
150
Registered
2013-03-14
Start date
2013-12-31
Completion date
2017-05-19
Last updated
2017-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

Metastatic, Quality of life, Decision making

Brief summary

Through a patient participation aid (PPA) the investigators hope to improve the psychosocial well-being of women diagnosed with metastatic breast cancer by empowering them to be active participants in clinical encounters.

Detailed description

The team has developed a brief Patient Participation Aid (PPA) to promote patient health literacy and encourage women to be active in the decisions that are being made about their healthcare which will lead to their satisfaction with healthcare and improves their psychosocial well-being. The paper-based PPA uses adult learning principles to limit and sequence plain language messages that have been framed from a patient's perspective. The PPA uses theory-based design to increase patients' involvement in the medical visit by modeling - through text and images - how a patient can: 1) set the visit agenda, 2) formulate questions, and 3) assert personal preferences. The specific aims of this study are to: 1- Assess the effectiveness of the PPA to increase patient involvement during clinical encounters. 2- Evaluate the effectiveness of the PPA to improve patient psychosocial outcomes. 3- Explore if the effect of the PPA varies by patients' literacy skills. To achieve this aims, the investigators will conduct a randomized controlled trial to evaluate the PPA among patients with a new diagnosis or progression of metastatic breast cancer at two cancer centers that serve diverse patient populations.

Interventions

BEHAVIORALPatient-Participation Aid

The PPA consists of a folder that addresses the three behaviors we hope to influence: agenda setting, asking questions, and making preferences known. The information inside contains sample questions for each section, with room for the patient to write her own questions. Each section models behavior by giving context for the items and specific example questions. It also addresses barriers to understanding by indicating that it is acceptable to ask questions when something is not clear or terms are unfamiliar.

Sponsors

American Cancer Society, Inc.
CollaboratorOTHER
Northwestern University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
FEMALE
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* female patients with metastatic breast cancer seeing one of the study physicians at one of the identified study clinics * age 21 or older * having suspected progression of metastatic disease

Exclusion criteria

* patients with an uncorrectable hearing impairment or having limited English proficiency, as this would adversely affect their ability to communicate with the physician * patients with uncorrectable vision impairment, as this would make it impractical for the patient to read the intervention * patients too ill to meaningfully converse with the physician

Design outcomes

Primary

MeasureTime frameDescription
Functional Assessment of Cancer Therapy - General (FACT-G)Change in functional assessment of cancer therapy from pre-visit at 3 months post-visitEvaluated at 30 minutes prior to, one week after, and 3 months after the patients visit with their doctor, this measure collects scales of the social and family well-being, emotional well-being, and functional well-being.

Secondary

MeasureTime frameDescription
Rapid Estimate of Adult Literacy in Medicine (REALM-SF)Pre-VisitA 7-item word recognition test to provide clinicians with a valid quick assessment of patient health literacy.

Other

MeasureTime frameDescription
Decision Regret ScaleChange in decision regret from pre-visit at 3 months post-visitCollected at post-visit, and follow-ups, this measures the patient's regret and feelings regarding the most recent treatment-related decision

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026